Enbrel 25mg Flakon

Etanercept is a biologic disease-modifying antirheumatic drug (DMARD) used in the treatment of autoimmune diseases such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and plaque psoriasis. It works by inhibiting the activity of tumor necrosis factor alpha (TNF-alpha), a cytokine involved in the inflammatory process. By binding to TNF-alpha and preventing it from binding to its receptors, Etanercept reduces inflammation, alleviates joint pain, stiffness, and swelling, and helps to slow down joint damage and disease progression in conditions like rheumatoid arthritis and psoriatic arthritis.

One of the key features of Etanercept is its ability to provide long-term relief from symptoms and improve overall disease outcomes in patients with autoimmune conditions. It is administered via subcutaneous injection and is available in various formulations, including prefilled syringes and autoinjectors, allowing for convenient self-administration at home. Etanercept has been shown to be effective in reducing disease activity, improving physical function, and enhancing quality of life in patients with autoimmune diseases, particularly those who have not responded adequately to conventional DMARDs or other biologic agents.